SONM logo

DNA X INC

SONMNASDAQ
πŸ† #5142 by market capEarnings Nov 17US Equity
$4.19β–Ό $0.15 (βˆ’3.68%)
πŸŒ™ After hours$4.19β–² 0.00%Regular close Β· extended-hours price shown
πŸ””
Track SONM
Get earnings, price moves & breaking news on Telegram
Track
24hβ–Ό 3.7%
7dβ–Ό 4.0%
14dβ–² 43.5%
30dβ–² 39.7%
ytdβ–² 31.8%
1yβ–Ό 62.7%
🏦Market Cap
$6M
Small Cap
πŸ“ˆRevenue Growth (YoY)
-100.0%
Declining
πŸ“ŠGross Margin
48.4%
Healthy
πŸ’΅FCF Margin
52.3%
Strong
βš–οΈP/S Ratio
-0.2x
Cheap
Otter Score
60
Fair

Trading Snapshot

Day Range
$4.16 – $4.22
52-Week Range
$2.52 – $16.97
Volume
$2.95B
Avg Volume
$3.35B
Shares Outstanding
1.5M
Next Earnings
Nov 16, 2026

Fundamentals Snapshot

Annual Revenue
$611,358
Last Q Revenue
$141,178
P/E Ratio
-3.1
P/S Ratio
-0.2x
EPS (TTM)
$-6.33
Dividend Yield
0.00%
Dilution (1yr)
+4598.2%

Why Investors Own SONM

  • βœ“High-growth profile β€” revenue up +22.0% YoY with expanding US Equity exposure.
  • βœ“Healthy economics β€” 41% gross margin and 25% free-cash-flow margin.
  • βœ“New products and segments could unlock additional revenue streams.
⚠️ Key Risks

Execution delays, intensifying competition, and valuation compression if growth decelerates.

SONM logo

DNA X INC

SONM
Financial Trends
RevenueThe total money the company brought in from sales, before subtracting any costs.
$0β–Ό βˆ’100.0% YoY
Gross MarginOf every $1 of sales, how much is left after the direct cost of making the product/service. Higher = more efficient.
17.0%β–Ό βˆ’17.6% YoY
Operating IncomeProfit from the core business after operating costs, but before interest and taxes. Negative means the core business isn’t profitable yet.
βˆ’$5Mβ–Ό βˆ’83.9% YoY
Free Cash FlowCash left over after running the business and paying for equipment/capex. Negative means the company is burning cash.
βˆ’$24Mβ–² +170.4% YoY
Shares OutstandingHow many shares exist. Rising means the company is issuing more shares, which dilutes (shrinks) each existing owner’s slice.
13.0Mβ–² +4598.2% YoY
Net CashCash minus total debt. Positive = more cash than debt (financially strong); negative = more debt than cash (net debt).
βˆ’$4Mβ–Ό βˆ’$9M YoY
StockOtter Β· stockotter.space

About DNA X INC

DNA X, Inc., formerly known as Sonim Technologies, Inc. until its rebranding in January 2026, is a company established in 1999 and headquartered in San Diego, California. The firm specializes in delivering enterprise-grade 5G solutions across a broad international footprint, encompassing the United States, Canada, Europe, the Middle East, and the Asia-Pacific region. Their product portfolio includes a comprehensive range of ruggedized communication devices tailored for frontline and task workers. This lineup features models such as the Sonim XP10, Sonim XP5plus, Sonim XP3plus, Sonim XP Pro, as well as the XP100 4G and XP400 5G professional rugged phones, XP Pro 5G rugged smartphones, and XP3plus 5G rugged flip phones. Beyond handsets, DNA X, Inc. also provides connected solutions, offering both fixed wireless access and mobile hotspot devices. These include the Sonim H100 low- and mid-range mobile hotspots, the Sonim H700, and the advanced Sonim H500-series of 5G mobile hotspots. Complementing its hardware offerings, the company supplies proprietary SonimWare software and a selection of industrial-grade accessories. DNA X, Inc. distributes its products through a diverse network that includes wireless carriers, data device distributors, communications system integrators, and electronics resellers. The company's clientele spans various critical industries, including transportation and logistics, construction, manufacturing, facilities management, energy and utilities, mining, federal government agencies, and public safety organizations.

🦦

Otter Score Breakdown

How it's scoredFive components, each rated 1–5β˜… and equally weighted (20%), averaged to a 0–100 score:πŸ’Ž Quality β€” gross marginπŸš€ Growth β€” revenue YoYβš–οΈ Valuation β€” P/S ratio⚑ Momentum β€” 30-day price changeπŸ’§ Dilution β€” 1-yr share issuance (buybacks score higher)
πŸ’ŽQualityβ˜…β˜…β˜…β˜…β˜…
πŸš€Growthβ˜…β˜…β˜…β˜…β˜…
βš–οΈValuationβ˜…β˜…β˜…β˜…β˜…
⚑Momentumβ˜…β˜…β˜…β˜…β˜…
πŸ’§Dilutionβ˜…β˜…β˜…β˜…β˜…
Overall Score
Fair
60/100

Analyst Price Target

β“˜
Average Target
$5.25
β–² +25.2% Upside
High Target$6.36
Low Target$4.85
Based on 16 analysts

Latest News & Updates